Study title:
Pezzotta-S, Knerich-R, Butti-G.
ICNG Coord. Cent., Neurosurg. Clin., Univ. Pavia, 27100 Pavia, Italy.
Chemotherapy for medulloblastoma in children. Current status and future prospects.
Child's Brain {CHILD-S-BRAIN}, 1982, Vol/Iss/Pg. 9/3-4 (294-298).Pezzotta-S, Knerich-R, Butti-G.
ICNG Coord. Cent., Neurosurg. Clin., Univ. Pavia, 27100 Pavia, Italy.
Chemotherapy for medulloblastoma in children. Current status and future prospects.
Child's Brain {CHILD-S-BRAIN}, 1982, Vol/Iss/Pg. 9/3-4 (294-298).
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|